tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market

Compare Ascendis Pharma (ASND) vs. Competitors

Compare
680 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascendis Pharma
$215.04
$13.28B
-50.63
59.44%
13 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$55.07
$10.77B
20.63
-10.57%
14 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$45.23
$12.13B
19.13
21.92%
6 Buy
8 Hold
1 Sell
Moderate Buy
Madrigal Pharmaceuticals
$495.88
$11.47B
-38.12
80.71%
10 Buy
2 Hold
0 Sell
Strong Buy
United Therapeutics
$471.99
$20.48B
17.89
30.51%
6 Buy
3 Hold
0 Sell
Moderate Buy
BridgeBio Pharma
$77.90
$15.01B
-18.21
117.89%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ASND
Ascendis Pharma
215.04
86.91
67.83%
BMRN
BioMarin Pharmaceutical
55.07
-6.46
-10.50%
EXEL
Exelixis
45.44
9.24
25.52%
MDGL
Madrigal Pharmaceuticals
495.88
202.24
68.87%
UTHR
United Therapeutics
471.99
113.06
31.50%
BBIO
BridgeBio Pharma
76.26
42.47
125.69%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts